期刊文献+

胰岛素促泌剂与强化胰岛素交替治疗对不同病程2型糖尿病胰岛功能的影响 被引量:3

THE EFFECT OF INSULIN SECRETAGOGUES AND INTENSIVE INSULIN ALTERNATING THERAPY ON THE PANCREATIC ISLAND FUNCTION IN DIFFERENT COURSES OF TYPE 2 DIABETIC PATIENTS
原文传递
导出
摘要 目的观察胰岛素促泌剂与强化胰岛素交替治疗对不同病程2型糖尿病胰岛功能的影响。方法将病程0~10年2型糖尿病498例,随机分为三组,治疗组病程<5年为A1组,162例,5~10年为A2组,167例,治疗24个月,对照组169例,平均(6.57±3.18)岁。观察二组患者治疗前后空腹及餐后2h血糖、糖化血红蛋白、空腹及餐后2h胰岛素的变化,计算胰岛β细胞功能指数及胰岛素抵抗指数。结果治疗24个月后,三组患者空腹、餐后2h血糖、糖化血红蛋白较治疗前明显下降(P<0.01),A1、A2组空腹、餐后2h胰岛素、胰岛β细胞功能指数较治疗前升高(P<0.05或0.01),对照组较治疗前升高,但无统计学意义,A1、A2组胰岛素抵抗指数较治疗前明显下降(P<0.05或0.01),对照组无变化;A1、A2组空腹、餐后2h血糖、糖化血红蛋白之间比较差异无统计学意义(P>0.05),A1组空腹、餐后2h胰岛素、胰岛β细胞功能指数显著高于A2组(P<0.05),而A1组胰岛素抵抗指数明显低于A2组(P<0.05);A1、A2组空腹、餐后2h血糖、糖化血红蛋白与对照组比较差异无统计学意义(P>0.05),但空腹、餐后2h胰岛素、胰岛β细胞功能指数明显高于对照组(P<0.05或0.01),而胰岛素抵抗指数明显低于对照组(P<0.05或0.01)。结论胰岛素促泌剂与强化胰岛素交替治疗不同病程2型糖尿病可有效保护胰岛β细胞功能,减轻胰岛素抵抗,越早使用交替治疗,效果越好。 Objective To study the effect of Insulin secretagogues and intensive Insulin alternating therapy on the pancreatic Island function in different courses of type 2 diabetes mellitus(DM).Methods 498 cases of type 2 DM which the course of disease 0-10 years were randomly divided into the treated group and control group(average age,6.57±3.18 years).The treated group were divided into A1 and A2 group,A1 group(n=162,the course of disease is less than 5 years),A2 group(n=167,the course of disease is 5-10 years),control group(n=169),for 24 months.The changes in the FPG、2-h PG、HbA1c、FINS、2-hINS were observed,islet cell function index(HBCI) and Insulin resistance index(IRI) were calculated before and after treatment.Results The treated group and control group were treated with 24 months,FPG、2-h PG and HbA1c decreased obviously before the treatment(P0.01).FINS、2-hINS and HBCI of the treated group increased before the treatment(P0.05,P0.01).The control group also increased,no statistically significant.IRI of the treated group decreased obviously before the treatment(P0.05,P0.01),but the controls no change.FPG、2-h PG and HbA1c between A1 and A2 group were no obvious difference(P0.05);FINS、2-hINS and HBCI of A1 group were significantly higher than A2 group(P0.05),IRI of A1 group was significantly lower than A2 group(P0.05).FPG、2-h PG and HbA1c between the treated and control group were no obvious difference(P0.05);FINS、2-hINS and HBCI of treated group were significantly higher than control group(P0.05,P0.01),IRI was lower than control group(P0.05).Conclusion Insulin secretagogues and intensive Insulin alternating therapy can effectively protect the islet function,reduce insulin resistance.The earlier use of alternative treatment,the better the results.
出处 《中国煤炭工业医学杂志》 2011年第11期1591-1593,共3页 Chinese Journal of Coal Industry Medicine
关键词 胰岛素促泌剂 强化胰岛素治疗 2型糖尿病 不同病程 胰岛Β细胞功能 Insulin secretagogues intensive Insulin therapy different course of type 2 diabetes Islet β cell function
  • 相关文献

参考文献5

二级参考文献19

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2于学满,赵晓娟,王璐.胰岛素治疗与胰岛B细胞休息的相关性研究[J].中国实用内科杂志,2005,25(4):313-314. 被引量:31
  • 3Seufert J, Weir G C, Habener J F, et al. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox-1 in rat pancreatic β cells during the development of diabetes mellitus [J]. J Clin Invest, 1998, 101: 2528-2539. 被引量:1
  • 4Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene β-cell-type promoter: An essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells [J]. Diabetes, 1996,45: 1478-1488. 被引量:1
  • 5Waeber G, Thompson N, Nicod P, et al. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor[J]. Mol Endocrinol, 1996,10:1327-1333. 被引量:1
  • 6Briaud I, Rouault C, Reach G, et al. Long-term exposure of isolated rat islet of Langerhans to supraphysiologic glucose concentrations decrease insulin mRNA levels [J]. Metabolism, 1999,48: 319-323. 被引量:1
  • 7Poitout V, Olson L K, Robertson R P, et al. Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator[J]. J Clin Invest, 1996,97:1041-1046. 被引量:1
  • 8Shim H, Dolde C, Lewis B C, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth[J]. Proc Natl Acad Sci USA, 1997,94: 6658-6663. 被引量:1
  • 9Jonas J C, Sharma A, Hasenkamp W, et al. Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes [J]. J Biol Chem, 1999,274:14112-14121. 被引量:1
  • 10Shankar R R, Zhu J S, Baron A D, et al. Glucosamine infusion in rats mimics the β-cell dysfunction of non-insulin-dependent diabetes mellitus [J]. Metabolism, 1998,47: 573-577. 被引量:1

共引文献32

同被引文献30

  • 1过依,洪洁,顾卫琼,张翼飞,王卫庆,毕宇芳,赵咏桔,宁光.不同胰岛素促泌剂对胰岛β细胞分泌胰岛素的影响[J].中华内分泌代谢杂志,2005,21(3):206-210. 被引量:43
  • 2张薇薇,盛正妍,王煜非.维生素D及其受体基因多态性与1型糖尿病[J].中国综合临床,2006,22(10):953-954. 被引量:5
  • 3吴晓萍,杨洋.不同胰岛素促泌剂对胰岛β细胞分泌功能的影响[J].吉林医学,2006,27(8):880-881. 被引量:1
  • 4Ogo A,Hiramatsu S,Watanabe A,et al.Short term intensiveinsulin therapy improves insulin secretion significantly in type 2diabetic patients[J].Fukuoka Igaku Zasshi,2006,97 (9):277-784. 被引量:1
  • 5Goykhman S,Drincic A,Desmangles JC,et al.Insulin glargine:areview 8 years after its introduction[J].Expert OpinPharmacother,2009,10(4):705-718. 被引量:1
  • 6McFarlane SI,Chaiken RL,Hirsch S,et al.Near-normoglycaemicremission in African-Americans with Type 2 diabetes mellitus isassociated with recovery of beta cell function[J].Diabet Med,2001,18(1):10-16. 被引量:1
  • 7Merlino LA,Curtis J,Mikuls TR,et al.Vitamin D in take is inversely associated with rheumatoid arthritis:results from the Iowa Women's Health Study[J].Arthritis Rheum,2004,50(1):72-77. 被引量:1
  • 8Pittas AG,Lau J,Hu F,at al.The role of vitamin D and calcium in type 2 diabetes.A system atic review and meta-analysis[J].Clin Endocrinol Metab,2007,92(6):2017-2029. 被引量:1
  • 9Mattila C,Knekt P,Maannisto S,et al.Serum25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes[J].Diabetes Care,2007,30(10):2569-2570. 被引量:1
  • 10Hollis BW.Assessment of vitamin Dstatus and definition of a normal circulating range of 25-hydroxyvitamin D[J].Curr Opin Endocrinol Diabetes Obes,2008,15(6):489-494. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部